Praxis Precision Medicines (PRAX) Earnings Analysis

Praxis Precision Medicines (PRAX) next reports earnings on 2026-08-03, consensus EPS -3.66837 USD. Last quarter (2026-05-07) it beat with EPS -3.2 USD vs -3.58 USD est (+10.6%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -23.31.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PRAX next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-3.66837 USD
Revenue estimate0.00B

PRAX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-3.2 USD-3.58 USD+10.6%Beat
2026-02-19-3.5 USD-3.12593 USD-12%Miss
2025-08-04-3.31 USD-3.4 USD+2.6%Beat
2025-05-02-3.29 USD-3.2 USD-2.8%Miss
2025-02-28-2.94 USD-2.76 USD-6.5%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

PRAX valuation and analyst view

Trailing P/E-23.31
Trailing EPS-11.30514 USD
Price / book6.39
Dividend yield0.00%
Market cap6.53B
Analyst consensusBuy (12 buy / 3 hold / 1 sell)
Avg price target587.86 USD

Related research pages

Frequently asked questions

When is Praxis Precision Medicines (PRAX)'s next earnings date?

Praxis Precision Medicines is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -3.66837 USD and revenue estimate of 0.00B.

Did PRAX beat earnings last quarter?

In its 2026-05-07 report, PRAX posted EPS of -3.2 USD versus a -3.58 USD estimate — a beat of 10.6%.

What is PRAX's earnings track record?

Over the last 5 reported quarters with consensus data, PRAX beat estimates 2 times (40%).

What is PRAX's current P/E ratio and EPS?

PRAX trades at a trailing P/E of -23.31 on trailing EPS of -11.305136659576599 USD.

What do analysts rate PRAX?

Analyst consensus is "Buy" across 16 ratings (0 strong buy, 12 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 587.86 USD.